Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.

By E. Bel, Sally E. Wenzel, P. Thompson, C. Prazma, O. Keene, S. Yancey, H. Ortega, I. Pavord. New England Journal of Medicine, 2014

1,472 citations recorded by the source corpus.

Subfields: Physiology, Sociology and Political Science, Surgery

View Paper: https://www.semanticscholar.org/paper/624dfa3aa02666077dde4f47ce1391d2eee5c8f6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Klion
2. M. Cid
3. U. Specks
4. P. Merkel
5. R. Luqmani
6. P. Weller
7. P. Khoury
8. J. Steinfeld

Citations in the corpus

• Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis (2017, background): “Remission within the first 24 wk that was sustained until wk 52 13 (19) 1 (1) 19.”